Search Results - Samol, Jens, MD

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial

    Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial by Chong, Wan-Qin, MBBS, Low, Jia-Li, MBBS, Tay, Joshua K, PhD, Le, Thi Bich Uyen, BSc, Goh, Grace Shi-Qing, BSc, Sooi, Kenneth, MBBS, Teo, Hui-Lin, MBBS, Cheo, Seng-Wee, MD, Wong, Regina Tong-Xin, BSc, Samol, Jens, MD, Lim, Ming-Yann, MBBS, Li, Hao, MBBS, Shirgaonkar, Niranjan, MSc, Chia, Shumei, PhD, Wang, Lingzhi, PhD, Gopinathan, Anil, MBBS, Eu, Donovan Kum-Chuen, MBBS, Tsang, Raymond King-Yin, MBChB, Loh, Kwok-Seng, Prof, Toh, Han-Chong, Prof, Syn, Nicholas, MBBS, Kong, Li-Ren, PhD, Dasgupta, Ramanuj, PhD, Tai, Bee-Choo, PhD, Lim, Yaw-Chyn, PhD, Goh, Boon-Cher, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Novel Options in Metastatic and Non-surgically Curable Bladder Cancer

    Novel Options in Metastatic and Non-surgically Curable Bladder Cancer by Vong, Elise, Samol, Jens

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: